Protocol: does sodium nitrite administration reduce ischaemia-reperfusion injury in patients presenting with acute ST segment elevation myocardial infarction? Nitrites in acute myocardial infarction (NIAMI)
Open Access
- 6 May 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Translational Medicine
- Vol. 11 (1), 116-8
- https://doi.org/10.1186/1479-5876-11-116
Abstract
Background Whilst advances in reperfusion therapies have reduced early mortality from acute myocardial infarction, heart failure remains a common complication, and may develop very early or long after the acute event. Reperfusion itself leads to further tissue damage, a process described as ischaemia-reperfusion-injury (IRI), which contributes up to 50% of the final infarct size. In experimental models nitrite administration potently protects against IRI in several organs, including the heart. In the current study we investigate whether intravenous sodium nitrite administration immediately prior to percutaneous coronary intervention (PCI) in patients with acute ST segment elevation myocardial infarction will reduce myocardial infarct size. This is a phase II, randomised, placebo-controlled, double-blinded and multicentre trial. Methods and outcomes The aim of this trial is to determine whether a 5 minute systemic injection of sodium nitrite, administered immediately before opening of the infarct related artery, results in significant reduction of IRI in patients with first acute ST elevation myocardial infarction (MI). The primary clinical end point is the difference in infarct size between sodium nitrite and placebo groups measured using cardiovascular magnetic resonance imaging (CMR) performed at 6–8 days following the AMI and corrected for area at risk (AAR) using the endocardial surface area technique. Secondary end points include (i) plasma creatine kinase and Troponin I measured in blood samples taken pre-injection of the study medication and over the following 72 hours; (ii) infarct size at six months; (iii) Infarct size corrected for AAR measured at 6–8 days using T2 weighted triple inversion recovery (T2-W SPAIR or STIR) CMR imaging; (iv) Left ventricular (LV) ejection fraction measured by CMR at 6–8 days and six months following injection of the study medication; and (v) LV end systolic volume index at 6–8 days and six months. Funding, ethics and regulatory approvals This study is funded by a grant from the UK Medical Research Council. This protocol is approved by the Scotland A Research Ethics Committee and has also received clinical trial authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) (EudraCT number: 2010-023571-26). Trial registration ClinicalTrials.gov: NCT01388504 and Current Controlled Trials: ISRCTN57596739Keywords
This publication has 34 references indexed in Scilit:
- Nitrite Therapy After Cardiac Arrest Reduces Reactive Oxygen Species Generation, Improves Cardiac and Neurological Function, and Enhances Survival via Reversible Inhibition of Mitochondrial Complex ICirculation, 2009
- Cardiac MRI of myocardial salvage at the peri-infarct border zones after primary coronary interventionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Myocardial protection by nitriteCardiovascular Research, 2009
- Nitrite Reductase Activity of Cytochrome cJournal of Biological Chemistry, 2008
- Mechanisms Underlying Erythrocyte and Endothelial Nitrite Reduction to Nitric Oxide in HypoxiaCirculation Research, 2008
- The functional nitrite reductase activity of the heme-globinsBlood, 2008
- Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemia-reperfusion injuryProceedings of the National Academy of Sciences, 2008
- Nitrite Anion Provides Potent Cytoprotective and Antiapoptotic Effects as Adjunctive Therapy to Reperfusion for Acute Myocardial InfarctionCirculation, 2008
- Myocardial Reperfusion InjuryNew England Journal of Medicine, 2007
- Intermittent Coronary Occlusion in Acute Myocardial InfarctionNew England Journal of Medicine, 1987